Clinical trial

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

NCT06690970

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2020-09-01

PhaseN/A

Study timeline

Study start (actual)2020-09-01Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PSMA-related Diseaseunresolved

Prostate Cancerunresolved

Positron Emission Tomographyunresolved

Metastasisunresolved

FAPunresolved

Hepatic Cancerunresolved

Interventions

68Ga/18F-PSMA/PSFADIAGNOSTIC_TEST

Sponsors & collaborators

Tianjin Medical Universitylead sponsor

Tianjin Medical University General Hospitalcollaborator

Mapped research locations

TianjinTianjin Municipality, China1 HefeiAnhui, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06690970 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.